Soterenol

Last updated

Soterenol
Soterenol.svg
Clinical data
Other namesMJ-1992
Drug class Adrenergic; Bronchodilator; Antiasthmatic; β-Adrenergic receptor agonist
Identifiers
  • N-[2-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C12H20N2O4S
Molar mass 288.36 g·mol−1
3D model (JSmol)
  • CC(C)NCC(C1=CC(=C(C=C1)O)NS(=O)(=O)C)O
  • InChI=1S/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3
  • Key:HHRNQOGXBRYCHF-UHFFFAOYSA-N

Soterenol (INN Tooltip International Nonproprietary Name), also known as soterenol hydrochloride (USAN Tooltip United States Adopted Name; developmental code name MJ-1992) in the case of the hydrochloride salt, is a drug of the phenethylamine family described as an adrenergic, bronchodilator, and antiasthmatic which was never marketed. [1] [2] [3] It is an analogue of salbutamol and acts as a β-adrenergic receptor agonist. [3] [2] The drug was first developed in 1964 [3] and was first described in the literature by 1967. [1]

References

  1. 1 2 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 1107. ISBN   978-1-4757-2085-3 . Retrieved 17 October 2024.
  2. 1 2 Morton I, Morton I, Hall J (1999). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 260. ISBN   978-0-7514-0499-9 . Retrieved 17 October 2024.
  3. 1 2 3 Sneader W (2005). Drug Discovery: A History. Wiley. p. 191. ISBN   978-0-471-89979-2 . Retrieved 17 October 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.